AHA responds to Medicare $2 Drug List Model request for information

Dec 09, 2024 - 04:00 PM
Prescription Drug Pricing. Green and white capsules on a pharmacy counter.

The AHA Dec. 9 said it supports a potential Medicare $2 Drug List Model, where people enrolled in a Part D plan would have access to certain prescription drugs for a low, fixed copayment no higher than $2 for a month’s supply per drug.  
 
"Providing low, fixed copayments for common generic drugs, as CMS proposed, could help increase medication adherence and improve health outcomes," AHA wrote. "This model would standardize cost sharing for certain drugs for beneficiaries with Medicare Part D enrolled in a participating plan and their health care providers." 
 
The AHA provided recommendations for how to account for shortages in the approved drug list and for public rulemaking to update the drug list annually, as well as feedback on potential quality measures for the model. Additional details on the request for information can be found on the M2DL webpage. Comments on the model are due to the Centers for Medicare & Medicaid Services today and must be submitted through a survey portal.

Related News Articles

Headline
CMS releases 2027 Medicare Advantage, Part D star ratings 
The Centers for Medicare & Medicaid Services has released 2027 Medicare Advantage plan information, including star ratings, through the Medicare Plan…
Headline
AHA comments to MedPAC on differences in post-acute care use between MA, fee-for-service Medicare beneficiaries
The AHA provided comments to the Medicare Payment Advisory Commission Oct. 2 on a discussion from the commission’s September meeting on its examination of…
Headline
CMS finalizes GLOBE drug pricing model
The Centers for Medicare & Medicaid Services Sept. 30 finalized its Global Benchmark for Efficient Drug Pricing Model, also known as the GLOBE Model. The…
Headline
CMS to expand IRF claim review demonstration to all facilities billing the jurisdiction that includes Alabama, Georgia, Tennessee
The Centers for Medicare & Medicaid Services announced Sept. 25 that it will expand the Inpatient Rehabilitation Facility Review Choice Demonstration to…
Headline
CMS projects decline in MA, small increase in standalone Part D premiums for 2027 
The Centers for Medicare & Medicaid Services announced Sept. 28 that it projects declines in average premiums for Medicare Advantage and Part D in 2027.…
Headline
CMS says all states have applied for GENEROUS Model to provide most-favored-nation drug pricing
The Centers for Medicare & Medicaid Services announced Sept. 18 that all 50 states, Washington, D.C., and Puerto Rico have applied to participate in its…